- CA$24.27m
- CA$28.37m
Brief: Pivot Pharmaceuticals Re-Brands As BetterLife Pharma
Brief: Pivot Pharma Launches Canadian Cannabis And Nutraceutical Manufacturing Facility
Brief: Pivot Pharma Enters U.S. CBD Market With Its Proprietary CBD Product Line
Brief: PIVOT Responds To Stockwatch Article On Notice Of Claim Filed By Aly Ismail
Brief: Pivot Pharma Announces C$15 Million Private Placement And Partnership
Brief: Pivot Pharma Develops Transdermal Patch for Delivery of CBD and THC
Brief: Emerald Health Says Entered Agreement Settling Claims Made By Pivot Pharmaceuticals